Comparison of a Point-Of-Care Test for High-Sensitivity C-Reactive Protein with an Established Immuno-Nephelometric

Clinical Laboratory
|December 9, 2015
PubMed

Insights

A new point-of-care test (POCT) for high-sensitivity C-reactive protein (hsCRP) shows moderate agreement with lab methods. This cardiovascular risk marker test could be improved by minimizing sample volume.

Area of Science:

  • Biochemistry
  • Clinical Diagnostics
  • Cardiovascular Medicine

Background:

  • High-sensitivity C-reactive protein (hsCRP) is a key indicator of cardiovascular risk, especially in primary prevention.
  • Traditional hsCRP measurement relies on automated laboratory methods.
  • There is a need for point-of-care tests (POCT) to enable faster and simpler hsCRP determination.

Purpose of the Study:

  • To evaluate a novel hsCRP point-of-care test (POCT).
  • To compare the POCT's performance against a standard nephelometric method for measuring hsCRP.

Main Methods:

  • A novel hsCRP POCT was compared with a standard nephelometric assay.
  • The study included 104 patients with diverse cardiovascular risk profiles.

Main Results:

  • The hsCRP POCT demonstrated moderate agreement with the established nephelometric method.
  • The test achieved 87% sensitivity and 80% specificity for detecting elevated hsCRP levels (greater than 1 mg/L).

Conclusions:

  • The novel hsCRP POCT offers a viable alternative for rapid assessment of cardiovascular risk.
  • Future improvements in hsCRP POCTs may involve minimizing sample volume for enhanced efficiency.
Abstract